Preclinical News and Research

RSS
Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Researchers discover new way to force cancer cells to self-destruct

Researchers discover new way to force cancer cells to self-destruct

SERI selects AB SCIEX TripleTOF 5600 system to test chronic eye inflammations

SERI selects AB SCIEX TripleTOF 5600 system to test chronic eye inflammations

Alzheimer’s diagnostic guidelines released

Alzheimer’s diagnostic guidelines released

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Cumberland acquires Vanderbilt's ifetroban rights

Cumberland acquires Vanderbilt's ifetroban rights

Seattle enters second ADC research collaboration agreement with Genmab

Seattle enters second ADC research collaboration agreement with Genmab

National Institute on Aging/Alzheimer's Association update new dementia guidelines

National Institute on Aging/Alzheimer's Association update new dementia guidelines

BioSante, Aduro BioTech enter license agreement for GVAX cancer vaccines

BioSante, Aduro BioTech enter license agreement for GVAX cancer vaccines

BioSante licenses Pancreas and Prostate cancer vaccines to Aduro BioTech

BioSante licenses Pancreas and Prostate cancer vaccines to Aduro BioTech

CoDa Therapeutics raises $19.2 million in Series B financing

CoDa Therapeutics raises $19.2 million in Series B financing

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

RXi prices underwritten public offering of 11,950,000 shares of common stock

RXi prices underwritten public offering of 11,950,000 shares of common stock

Novartis, Duke sign deal to develop pandemic flu vaccine

Novartis, Duke sign deal to develop pandemic flu vaccine

The Wistar Institute, Advaxis enter research collaboration

The Wistar Institute, Advaxis enter research collaboration

Yissum announces successful Docetaxel pre-clinical data in cancer

Yissum announces successful Docetaxel pre-clinical data in cancer

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Early uMSC transplantation may treat lupus nephritis

Early uMSC transplantation may treat lupus nephritis

NCI awards MabVax with Phase II SBIR grant to develop vaccine against recurrent sarcoma

NCI awards MabVax with Phase II SBIR grant to develop vaccine against recurrent sarcoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.